AMAG Pharmaceuticals, Inc. Gets FDA Request for More Data on Anemia Drug

October 20, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

CAMBRIDGE, Mass. - Biotechnology company AMAG Pharmaceuticals Inc. said Monday the Food and Drug Administration wants more information on a prospective anemia drug before considering it for approval.

Twitter
LinkedIn
Facebook
Email
Print

FDA Approvals Regulatory

Food and Drug Administration (FDA)